Hoth Shares Rise After Alzheimer's Treatment Gets Patent

By MarketWatch | Oct 15, 2024 at 06:58 AM EST

Hoth Therapeutics' shares surged in pre-market trading after receiving a U.S. patent for its Alzheimer's treatment, HT-ALZ. The company is gearing up for clinical trials, focusing on a unique approach targeting neuroinflammation in Alzheimer's disease.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.